![Betty Chang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Betty Chang
Corporate Officer/Principal bei SUMMIT THERAPEUTICS INC.
Aktive Positionen von Betty Chang
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SUMMIT THERAPEUTICS INC. | Corporate Officer/Principal | 01.06.2021 | - |
Karriereverlauf von Betty Chang
Ehemalige bekannte Positionen von Betty Chang
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Angarus Therapeutics, Inc.
![]() Angarus Therapeutics, Inc. Hospital/Nursing ManagementHealth Services Angarus Therapeutics, Inc. engages in the development of immuno-oncology therapies. It specializes in modulating the tumor microenvironment by activating innate immunity. The company was founded by Ling Yin Li, Chih Ping Liu, and Mark Smith and is headquartered in Sunnyvale, CA. | Geschäftsführer | 01.01.2018 | 01.01.2019 |
PHARMACYCLICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2009 | 01.01.2018 |
ALDER BIOPHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.01.2009 | 01.11.2009 |
RIGEL PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.01.2004 | 01.01.2009 |
MOLECULAR TEMPLATES, INC. | Corporate Officer/Principal | - | - |
Ausbildung von Betty Chang
University of California, Davis | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 8 |
Operativ
Corporate Officer/Principal | 4 |
Chief Tech/Sci/R&D Officer | 1 |
Chief Operating Officer | 1 |
Sektoral
Health Technology | 6 |
Health Services | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
SUMMIT THERAPEUTICS INC. | Health Technology |
MOLECULAR TEMPLATES, INC. | Health Technology |
RIGEL PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
Pharmacyclics LLC
![]() Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Pharmacyclics LLC engages in developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. It has product candidates in clinical development and several preclinical molecules in optimization. The company was founded by Jonathan Sessler and Richard Miller in 1991 and is headquartered in Sunnyvale, CA. | Health Technology |
Angarus Therapeutics, Inc.
![]() Angarus Therapeutics, Inc. Hospital/Nursing ManagementHealth Services Angarus Therapeutics, Inc. engages in the development of immuno-oncology therapies. It specializes in modulating the tumor microenvironment by activating innate immunity. The company was founded by Ling Yin Li, Chih Ping Liu, and Mark Smith and is headquartered in Sunnyvale, CA. | Health Services |
Lundbeck Seattle BioPharmaceuticals, Inc.
![]() Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lundbeck Seattle BioPharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on transforming the migraine treatment paradigm through the discovery, development and commercialization of novel therapeutic antibodies. Its product includes Eptinezumab, is an investigational monoclonal antibody (mAb) that inhibits calcitonin gene-related peptide (CGRP) and is currently in late-stage clinical development for the prevention of migraine. The company was founded by Randall C. Schatzman, Mark J. Litton, and John A. Latham in January 2004 and is headquartered in Bothell, WA. | Health Technology |
- Börse
- Insiders
- Betty Chang
- Erfahrung